CluePoints’ Post

View organization page for CluePoints, graphic

10,220 followers

In a recent survey gathering 206 responses from industry leaders, we uncovered fascinating insights into 32 distinct RBQM practices. More than half of sponsors and CROs have already embraced RBQM approaches, signaling a transformative shift in how we manage risks in drug development. In our latest webinar featuring Ken Getz of Tufts Center for the Study of Drug Development, we explored these numbers. Now, you can watch on-demand: https://bit.ly/440BWmf 🗣 #ClinicalResearch #RBQM #Pharma #Biotech

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics